» Articles » PMID: 3326683

Regulatory Properties of Brain Glutamate Decarboxylase

Overview
Publisher Springer
Date 1987 Sep 1
PMID 3326683
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

1. Glutamate decarboxylase is a focal point for controlling gamma-aminobutyric acid (GABA) synthesis in brain. Several factors that appear to be important in the regulation of GABA synthesis have been identified by relating studies of purified glutamate decarboxylase to conditions in vivo. 2. The interaction of glutamate decarboxylase with its cofactor, pyridoxal 5'-phosphate, is a regulated process and appears to be one of the major means of controlling enzyme activity. The enzyme is present in brain predominantly as apoenzyme (inactive enzyme without bound cofactor). Studies with purified enzyme indicate that the relative amounts of apo- and holoenzyme are determined by the balance in a cycle that continuously interconverts the two. 3. The cycle that interconverts apo- and holoenzyme is part of the normal catalytic mechanism of the enzyme and is strongly affected by several probable regulatory compounds including pyridoxal 5'-phosphate, ATP, inorganic phosphate, and the amino acids glutamate, GABA, and aspartate. ATP and the amino acids promote apoenzyme formation and pyridoxal 5'-phosphate and inorganic phosphate promote holoenzyme formation. 4. Numerous studies indicate that brain contains multiple molecular forms of glutamate decarboxylase. Multiple forms that differ markedly in kinetic properties including their interactions with the cofactor have been isolated and characterized. The kinetic differences among the forms suggest that they play a significant role in the regulation of GABA synthesis.

Citing Articles

A review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for Parkinson disease.

Currie A, Wong J, Okun M NPJ Parkinsons Dis. 2024; 10(1):195.

PMID: 39443513 PMC: 11500395. DOI: 10.1038/s41531-024-00804-0.


Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations.

OHare L, Tarasi L, Asher J, Hibbard P, Romei V Int J Mol Sci. 2023; 24(12).

PMID: 37373244 PMC: 10299141. DOI: 10.3390/ijms241210093.


High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression.

Field D, Cracknell R, Eastwood J, Scarfe P, Williams C, Zheng Y Hum Psychopharmacol. 2022; 37(6):e2852.

PMID: 35851507 PMC: 9787829. DOI: 10.1002/hup.2852.


Using Steady-State Kinetics to Quantitate Substrate Selectivity and Specificity: A Case Study with Two Human Transaminases.

Peracchi A, Polverini E Molecules. 2022; 27(4).

PMID: 35209187 PMC: 8875635. DOI: 10.3390/molecules27041398.


Micronutrients May Be a Unique Weapon Against the Neurotoxic Triad of Excitotoxicity, Oxidative Stress and Neuroinflammation: A Perspective.

Holton K Front Neurosci. 2021; 15:726457.

PMID: 34630015 PMC: 8492967. DOI: 10.3389/fnins.2021.726457.


References
1.
Tapia R, Meza-Ruiz G . Differences in some properties of newborn and adult brain glutamate decarboxylase. J Neurobiol. 1975; 6(2):171-81. DOI: 10.1002/neu.480060205. View

2.
Sato S, Frazier J, Goldberg A . The distribution and binding of zinc in the hippocampus. J Neurosci. 1984; 4(6):1662-70. PMC: 6564987. View

3.
Wu J, Roberts E . Properties of brain L-glutamate decarboxylase: inhibition studies. J Neurochem. 1974; 23(4):759-67. DOI: 10.1111/j.1471-4159.1974.tb04401.x. View

4.
Chapman A, Croucher M, Meldrum B . Anticonvulsant activity of intracerebroventricularly administered valproate and valproate analogues. A dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice. Biochem Pharmacol. 1984; 33(9):1459-63. DOI: 10.1016/0006-2952(84)90413-1. View

5.
MILLER L, Walters J, Martin D . Post-mortem changes implicate adenine nucleotides and pyridoxal-5' -phosphate in regulation of brain glutamate decarboxylase. Nature. 1977; 266(5605):847-8. DOI: 10.1038/266847a0. View